Impact of operational factors on HPV positivity rates in an HPV-based screening study in Colombia
Authors:
- 16 July 2018
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 143 (1) , 44-51
Abstract
Objective To assess the effect of operational factors on the positivity rates of three HPV assays. Methods Within the cross‐sectional ESTAMPA study, women aged 30–64 years were recruited in healthcare centers from Soacha, Colombia, during 2012–2015. Cervical samples were collected for cotesting with Hybrid Capture 2 (HC2; Qiagen, Gaithersburg, MD, USA), and either Aptima (Hologic, Marlborough, MA, USA) or Cobas 4800 (Roche Diagnostics, Indianapolis, IN, USA). The effect of operational factors on assay performance was assessed using adjusted positivity rates obtained from logistic regression models. Results There were 4168 women included. For samples collected in assay‐specific medium, positivity rate differences were associated with the expertise of the nurse collecting the sample (P=0.014 HC2; P=0.091 Aptima) and if sample collection occurred after an initial cytology (P=0.025 HC2; P=0.033 Aptima). If PreservCyt medium (Hologic) was used, HC2 positivity differences were observed depending on the time between sample collection and processing (P=0.026) and on the laboratory technician processing the samples (P=0.003). No differences were observed for PreservCyt samples processed with Aptima or Cobas. Conclusion Nurse expertise, collection of previous cytology, processing time, and laboratory technician could influence HPV assay performance. Suitable quality assurance protocols for HPV‐based screening programs are required.Keywords
Funding Information
- Colombian National Cancer Institute
- United Nations Development Programme
- United Nations Population Fund
- United Nations Children's Fund
- World Health Organization
- World Bank Group
- US NCI Center for Global Health
This publication has 17 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Effect of Preanalytical Processing of ThinPrep Specimens on Detection of High-Risk Human Papillomavirus by the Aptima HPV AssayJournal of Clinical Microbiology, 2014
- Estimating predicted probabilities from logistic regression: different methods correspond to different target populationsInternational Journal of Epidemiology, 2014
- A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical CancerInternational Journal of Gynecological Cancer, 2014
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Cervical Cancer Screening Programs in Latin America and the CaribbeanVaccine, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- The Efficacy of Reprocessing Unsatisfactory Cervicovaginal ThinPrep Specimens With and Without Glacial Acetic AcidAmerican Journal of Clinical Pathology, 2002
- Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource SettingsJAMA, 2001